Zacks
  • Home
  • Analyst Bios
  • Research Reports
    • Companies by Analyst
      • Biotech - David Bautz, PhD
      • Biotech - John Vandermosten, CFA
      • Bank & Finance – Ann Heffron, CFA, CPA
      • Special Situations – Ian Gilson, PhD, CFA
      • Special Situations – Steven Ralston, CFA
      • Med-Tech – Brian Marckx, CFA
      • Med-Tech - Anita Dushyanth, PhD
      • Technology – Lisa Thompson
      • Technology - M. Marin
      • Healthcare - Beth Senko, CFA
    • Companies by Name
  • Distribution
    • Institutional Distribution
    • Retail Distribution
    • Social Media
    • RSS Feeds
  • Our Partners
    • IR Firms
  • Contact
  • Subscribe
    • Free Weekly Digest
    • Zacks SCR Premium
    • Zacks SCR On-Call
Latest

Notes in the Press

May 29, 2020 CFRX: Four Abstracts Published in 30th ECCMID Abstract Book; Financing Overhang Removed as Pfizer Makes Second Investment…
May 29, 2020 DYAI: Steady as She Goes
May 29, 2020 ACHV: When Quitting Gets You to the Finish Line
May 29, 2020 PHIO: Intasyl Advantage vs. Gene Editing
May 29, 2020 UHAL: Not expected to run out of cash! Fourth quarter numbers were much better than expected. Revenue is improving from the low in April 2020 and the relaxed restrictions should boost revenue from these levels. U-Box continues to grow and is profitable.
May 28, 2020 CVM: Last Event Completed; On To Analysis
May 28, 2020 LPCN: Cirrhosis IND Cleared
May 28, 2020 PMN.TO: Diagnostic Testing to the Forefront
May 28, 2020 MTBC: MTBC Weathering COVID Storm, Reaffirms 2020 Guidance. Growth Should Re-Materialize in 2H
May 27, 2020 CSSE: Viewership Accelerated in Q1 and Crackle+ Should Emerge Even Stronger This Fall
 

Invalid login, please try again. You have retries remaining before your account will be locked.

Your account is locked and it will be unlocked automatically in minutes.

User ID:
Password:
Remember my ID:

COPYRIGHT © ZACKS INVESTMENT RESEARCH 2020
  • Disclaimer
  • Privacy Policy
  • Site Map
Tweet Follow @ZacksSmallCap
Powered By Q4 Inc. 5.34.0.6